Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chains

Bioorganic & Medicinal Chemistry Letters
2004.0

Abstract

A series of benzoxathiin SERAMs with heteroatom-substituted amine side chains was prepared. Minor modifications in the side chain resulted in significant effects on biological activity, especially in uterine tissue.

Knowledge Graph

Similar Paper

Estrogen receptor ligands. Part 8: Dihydrobenzoxathiin SERAMs with heteroatom-substituted side chains
Bioorganic & Medicinal Chemistry Letters 2004.0
Estrogen receptor ligands. Part 7: Dihydrobenzoxathiin SERAMs with bicyclic amine side chains
Bioorganic & Medicinal Chemistry Letters 2004.0
Estrogen receptor ligands. Part 9: Dihydrobenzoxathiin SERAMs with alkyl substituted pyrrolidine side chains and linkers
Bioorganic & Medicinal Chemistry Letters 2005.0
Estrogen receptor ligands. Part 13: Dihydrobenzoxathiin SERAMs with an optimized antagonist side chain
Bioorganic & Medicinal Chemistry Letters 2005.0
Estrogen receptor ligands. Part 14: Application of novel antagonist side chains to existing platforms
Bioorganic & Medicinal Chemistry Letters 2005.0
Estrogen receptor ligands. Part 4: The SAR of the syn-dihydrobenzoxathiin SERAMs
Bioorganic & Medicinal Chemistry Letters 2004.0
Estrogen receptor ligands. Part 3: The SAR of dihydrobenzoxathiin SERMs
Bioorganic & Medicinal Chemistry Letters 2004.0
Benzothiophenes containing a piperazine side chain as selective ligands for the estrogen receptor α and their bioactivities in vivo
Bioorganic & Medicinal Chemistry Letters 2005.0
Estrogen Receptor Ligands. II. Discovery of Benzoxathiins as Potent, Selective Estrogen Receptor α Modulators
Journal of Medicinal Chemistry 2004.0
Benzothiophene Selective Estrogen Receptor Modulators with Modulated Oxidative Activity and Receptor Affinity
Journal of Medicinal Chemistry 2007.0